Suppr超能文献

巴西利卡汀A,一种来自巴西奴卡氏菌的新型萜类抗生素:发酵、分离及生物活性

Brasilicardin A, a new terpenoid antibiotic from pathogenic Nocardia brasiliensis: fermentation, isolation and biological activity.

作者信息

Komaki H, Nemoto A, Tanaka Y, Takagi H, Yazawa K, Mikami Y, Shigemori H, Kobayashi J, Ando A, Nagata Y

机构信息

Research Laboratory, Higeta Shoyu Co., Ltd., Choshi, Chiba, Japan.

出版信息

J Antibiot (Tokyo). 1999 Jan;52(1):13-9. doi: 10.7164/antibiotics.52.13.

Abstract

A novel tricyclic diterpenoid antibiotic, brasilicardin A, was isolated from the culture broth of Nocardia brasiliensis IFM 0406. The antibiotic exhibited immunosuppressive activity in a mouse mixed lymphocyte reaction (MLR) assay system and its IC50 value was 0.057 microg/ml. Although the inhibitory activity of cyclosporin A (CyA) against IL-2 production was confirmed in the MLR assay system, brasilicardin A did not have the activity. The results of in vitro toxicity testing of brasilicardin A against various human cell lines were compared with those of CyA.

摘要

一种新型三环二萜类抗生素——巴西卡迪菌素A,是从巴西诺卡氏菌IFM 0406的培养液中分离得到的。该抗生素在小鼠混合淋巴细胞反应(MLR)检测系统中表现出免疫抑制活性,其IC50值为0.057微克/毫升。尽管在MLR检测系统中证实了环孢素A(CyA)对白细胞介素-2产生的抑制活性,但巴西卡迪菌素A没有这种活性。将巴西卡迪菌素A对各种人类细胞系的体外毒性测试结果与环孢素A的测试结果进行了比较。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验